Multiple heparin binding domains of respiratory syncytial virus G mediate binding to mammalian cells

Arch Virol. 2003 Oct;148(10):1987-2003. doi: 10.1007/s00705-003-0139-0.

Abstract

Respiratory syncytial virus (RSV) G glycoprotein mediates cell attachment through surface glycosaminoglycans (GAGs). Feldman et al. [10] suggested that specific basic amino acids in residues 184-198 of G defined a critical heparin binding domain (HBD). To further define the G HBD we made a series of truncated G proteins expressed in Escherichia coli. G88 (G residues 143-231), bound to HEp-2 cells in a dose dependent manner and binding was inhibited >99% with heparin. Cell binding of G88 was unaltered by alanine substitution mutagenesis of all basic amino acids in Feldman's region 184-198. A G88 variant truncated beyond residue 198, G58, and G58 fully alanine substituted in the region 184-198, G58A6, bound to HEp-2 cells about half as well and 100-fold less well than G88, respectively. G88 and all alanine substitution mutants of G88 inhibited RSV plaque formation by 50% (ID(50)) at concentrations of approximately 50 nM; the ID(50) of G58 was approximately 425 nM while G58A6 had an ID(50) >1600 nM. These data show that the G HBD includes as much as residues 187-231, that there is redundancy beyond the previously described HBD, and that the cell-binding and virus infectivity-blocking functions of these recombinant G proteins were closely linked and required at least one HBD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • CHO Cells
  • Cricetinae
  • Gene Expression Regulation, Viral*
  • Heparin / metabolism*
  • Humans
  • Molecular Sequence Data
  • Mutation
  • Recombinant Proteins / metabolism
  • Respiratory Syncytial Viruses / metabolism*
  • Respiratory Syncytial Viruses / pathogenicity
  • Sequence Alignment
  • Tumor Cells, Cultured
  • Viral Plaque Assay
  • Viral Proteins / chemistry*
  • Viral Proteins / genetics
  • Viral Proteins / metabolism

Substances

  • Recombinant Proteins
  • Viral Proteins
  • Heparin